Head-to-Head

ABBVIE INC. vs. Eli Lilly & Co.

ABBV

ABBVIE INC.

$264.47 +0.17%

VS LLY

Eli Lilly & Co.

$1152.93 +0.04%

Eli Lilly & Co. (LLY) comes out ahead, leading on 7 of 11 compared factors.

Size & Scale

ABBVLLY
Market Cap $466.55 billion $1.03 trillion
Revenue (TTM) $64.39 billion $79.67 billion
Net Income (TTM) $6.32 billion $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

ABBVLLY
P/E Ratio 74.71 38.70
Price / Book -79.24 30.33
Price / Sales 7.25 12.90

ABBV leads on 2 of 3 valuation factors.

Profitability

ABBVLLY
Net Margin 9.81% 33.53%
Return on Equity -107.29% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

ABBVLLY
Dividend Yield 2.62% 0.60%
Payout Ratio 195.48 23.23

ABBV and LLY split the dividend factors evenly.

Risk & Sentiment

ABBVLLY
Short Interest 0.85% 1.29%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.